518 related articles for article (PubMed ID: 24961965)
1. Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock.
Park DW; Kwak DS; Park YY; Chang Y; Huh JW; Lim CM; Koh Y; Song DK; Hong SB
J Crit Care; 2014 Oct; 29(5):882.e5-11. PubMed ID: 24961965
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of lipopolysaccharide binding protein and procalcitonin in patients with severe sepsis and septic shock admitted to intensive care].
García de Guadiana-Romualdo LM; Rebollo-Acebes S; Esteban-Torrella P; Jiménez-Sánchez R; Hernando-Holgado A; Ortín-Freire A; Viqueira-González M; Trujillo-Santos J; Jiménez Santos E; Pedregosa Díaz J; Albaladejo-Otón MD; Allegue-Gallego JM
Med Intensiva; 2015 May; 39(4):207-12. PubMed ID: 24953001
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock].
Suberviola B; Castellanos-Ortega A; González-Castro A; García-Astudillo LA; Fernández-Miret B
Med Intensiva; 2012 Apr; 36(3):177-84. PubMed ID: 22055776
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.
Brunkhorst FM; Wegscheider K; Forycki ZF; Brunkhorst R
Intensive Care Med; 2000 Mar; 26 Suppl 2():S148-52. PubMed ID: 18470710
[TBL] [Abstract][Full Text] [Related]
5. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock.
Ríos-Toro JJ; Márquez-Coello M; García-Álvarez JM; Martín-Aspas A; Rivera-Fernández R; Sáez de Benito A; Girón-González JA
PLoS One; 2017; 12(4):e0175254. PubMed ID: 28380034
[TBL] [Abstract][Full Text] [Related]
6. [The predictor value of peripheral blood procalcitonin levels in the evaluation of prognosis of patients with septic shock].
Chen W; Li LJ; Gu XY; Wang SZ; Zhao L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Aug; 24(8):470-3. PubMed ID: 22871405
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell-specific molecule-1/endocan: Diagnostic and prognostic value in patients suffering from severe sepsis and septic shock.
Pauly D; Hamed S; Behnes M; Lepiorz D; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
J Crit Care; 2016 Feb; 31(1):68-75. PubMed ID: 26489483
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management.
Que YA; Delodder F; Guessous I; Graf R; Bain M; Calandra T; Liaudet L; Eggimann P
Crit Care; 2012 Jul; 16(4):R114. PubMed ID: 22748193
[TBL] [Abstract][Full Text] [Related]
10. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates.
Claeys R; Vinken S; Spapen H; ver Elst K; Decochez K; Huyghens L; Gorus FK
Crit Care Med; 2002 Apr; 30(4):757-62. PubMed ID: 11940741
[TBL] [Abstract][Full Text] [Related]
11. Reduction in procalcitonin level and outcome in critically ill children with severe sepsis/septic shock-A pilot study.
Poddar B; Gurjar M; Singh S; Aggarwal A; Baronia A
J Crit Care; 2016 Dec; 36():230-233. PubMed ID: 27566963
[TBL] [Abstract][Full Text] [Related]
12. Serum procalcitonin is a sensitive marker for septic shock and mortality in secondary peritonitis.
Pupelis G; Drozdova N; Mukans M; Malbrain ML
Anaesthesiol Intensive Ther; 2014; 46(4):262-73. PubMed ID: 25293477
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.
Liu B; Chen YX; Yin Q; Zhao YZ; Li CS
Crit Care; 2013 Oct; 17(5):R244. PubMed ID: 24138799
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.
Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ
J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850
[TBL] [Abstract][Full Text] [Related]
15. Pentraxin-3 Predicts Short- and Mid-term Mortality in Patients with Sepsis and Septic Shock During Intensive Care Treatment.
Hamed S; Behnes M; Pauly D; Lepiorz D; Barre M; Becher T; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
Clin Lab; 2018 Jun; 64(6):999-1011. PubMed ID: 29945330
[TBL] [Abstract][Full Text] [Related]
16. Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Δ Sequential Organ Failure Assessment.
de Azevedo JR; Torres OJ; Beraldi RA; Ribas CA; Malafaia O
J Crit Care; 2015 Feb; 30(1):219.e9-12. PubMed ID: 25241933
[TBL] [Abstract][Full Text] [Related]
17. Changes in circulating procalcitonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients.
Hoeboer SH; Groeneveld AB
PLoS One; 2013; 8(6):e65564. PubMed ID: 23762396
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of procalcitonin in patients with septic shock.
Clec'h C; Ferriere F; Karoubi P; Fosse JP; Cupa M; Hoang P; Cohen Y
Crit Care Med; 2004 May; 32(5):1166-9. PubMed ID: 15190968
[TBL] [Abstract][Full Text] [Related]
19. Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock.
Ryu JA; Yang JH; Lee D; Park CM; Suh GY; Jeon K; Cho J; Baek SY; Carriere KC; Chung CR
PLoS One; 2015; 10(9):e0138150. PubMed ID: 26367532
[TBL] [Abstract][Full Text] [Related]
20. Serum Procalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patients with Severe Sepsis and Septic Shock.
Huang MY; Chen CY; Chien JH; Wu KH; Chang YJ; Wu KH; Wu HP
Biomed Res Int; 2016; 2016():1758501. PubMed ID: 27088084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
